HIV Prevention
168
32
38
94
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
25 trials with published results (15%)
Research Maturity
94 completed trials (56% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.6%
6 terminated out of 168 trials
94.0%
+7.4% vs benchmark
10%
16 trials in Phase 3/4
27%
25 of 94 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 94 completed trials
Clinical Trials (168)
Leveraging Infant Visit PrEP INtegration & tasK Shifting to Improve Post-partum HIV Prevention in Malawi
Leveraging Chatbot to Improve PrEP in the Southern United States
Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals
Evaluation of a Differentiated Point-of-care Active Case Finding & Management Model to Eliminate Mother-to-Child Transmission of HIV in Malawi
Pharmacies in HIV Prevention: Fellowship, Fundamentals, and Sustainable Finances
Private-sector Access to Testing for Health Sustainability
Leveraging Video Logs as a Bridge to Pre-exposure Prophylaxis (PrEP) With Tailored Messaging to Black Women and Their Healthcare Providers in Texas.
Social Media as a Risk Tool for HIV Prevention Needs
Using PrEP, Doing It for Ourselves
Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP
PrEP-Pod-IVR (TDF-FTC/Placebo IVR 28 Day Crossover Study)
Enhancing HIV Prevention and Reducing Alcohol Use Among People Receiving STI Care in Lilongwe, Malawi
PrEP & Soccer: A Program for Pharmacy Chains to Increase PrEP Awareness and Access Among Men
Are Louisiana Pharmacists PrEPared? Implementing Training and an Active PrEP (Pre-Exposure Prophylaxis) Prescribing Surveillance Program
Optimizing Pre-Exposure Prophylaxis (PrEP) Among Latino Men Who Have Sex With Men (MSM) in Puerto Rico
Combatting HIV Or Other STIs Early (CHOOSE)
PEP/PrEP Via Pharmacist-Prescribing Implementation (PEPPI)
Safe Spaces 4 Sexual Health
An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South
Evaluating the Safety and Immunogenicity of Polyvalent DNA and Recombinant gp120 Protein HIV Vaccine (PDPHV) in Healthy, HIV-uninfected Adults